MPR Weekly Dose 87 - Statin contraindication change; Vaccine for streptococcus pneumoniae; Plaque psoriasis cream; Therapy fast tracked for Parkinson disease; Bylvay approved
This week we have news of the FDA requesting a change to statin prescribing labels, a new vaccine for streptococcus pneumoniae, a new plaque psoriasis cream, a stem cell therapy gets fast tracked as a...
23 Jul 202111min
MPR Weekly Dose Podcast Episode 86
This week on the pod we speak about a fact sheet update for the Janssen COVID vaccine. Pfizer and BioNTech are working on a booster version of their vaccine. A supplement is found to contain a prescri...
16 Jul 20218min
MPR Weekly Dose 85 - Chantix recalled; Kimyrsa for ABSSSI; Aduhelm label update; Blood lead test recall; Keytruda changes
This week Pfizer recalled their smoking cessation therapy Chantix. A treatment for acute bacterial skin and skin structure infections becomes available. Aduhelm, the newly approved Alzheimer Disease t...
9 Jul 20219min
MPR Weekly Dose 84 - Emergency Use for COVID-19 treatment; Fact sheet update for vaccines; Rylaze approved; Expanded approval for Solosec; NDA submitted for HIV-1 treatment
The FDA grants Emergency Use to Actemra to treat hospitalized COVID patients. Revisions are been made to the fact sheets for the Moderna and Pfizer BioNTech COVID vaccines to include information relat...
2 Jul 202112min
MPR Weekly Dose 83 - Rx-to-OTC for allergy spray; Novel contraceptive; Pediatric VTE Tx; Veklury real world efficacy data; Wearable thermometer
This week the FDA approved a first-in-class switch for an antihistamine nasal spray, a new oral contraceptive, and Pradaxa was approved to prevent venous thromboembolism in pediatric patients. Meanwhi...
24 Jun 202110min
MPR Weekly Dose 82 - A regenerative skin therapy; Novavax vaccine shows promise; Mastocytosis treatment; Potential new depression treatment; And an FDA warning for hand sanitizers.
This week the FDA approved a regenerative skin tissue therapy and a treatment for advanced mastocytosis, while Novavax's vaccine for COVID and a novel treatment for MDD show promise. Also the FDA issu...
17 Jun 20218min
MPR Weekly Dose 81 - A first therapy to target underlying process of Alzheimer disease; Moderna requests EUA; And a list of new approvals in a variety of therapeutic categories
This week it's the big one: aducanumab - a treatment for alzheimer disease - got FDA approval. We'll go into that, plus a semaglutide treatment for obesity, a first treatment for Plasminogen Deficienc...
11 Jun 202114min
MPR Weekly Dose 80 - Migraine prevention treatment; Pediatric combo vaccine; Schizophrenia, Bipolar I approval; AI-based Autism diagnostic
On this week's show we have news of migraine prevention treatment, a hexavalent vaccine is approved for pediatrics, there's also an approval for schizophrenia and bipolar I disorder, lumakras gets fas...
4 Jun 202110min
